COMPARISON OF EFFICACY OF FIXED-DOSE ROSUVASTATIN PLUS EZETIMIBE COMBINATION THERAPY VERSUS ROSUVASTATIN MONOTHERAPY IN CORONARY ARTERY DISEASE PATIENTS. (2025). The Research of Medical Science Review, 3(8), 539-545. https://www.medscireview.net/index.php/Journal/article/view/1865